Efficacy and safety of anlotinib combined with anthracycline and ifosfamide followed by anlotinib maintenance in advanced soft tissue sarcoma: A single-arm, phase 2 trial

被引：0
|
作者：
Liu, Zengjun
Liu, Mengyao
Xu, Jing
Hu, Wenyu
Zhu, Dongyuan
Tao, Rongjie
Xu, Ni
Zhang, Hui
Li, Minghuan
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Rare Tumors Dept, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Rare Tumors Dept, Jinan, Shandong, Peoples R China
[3] Shandong Canc Hosp & Inst, Rare Tumors Dept, Jinan, Peoples R China
[4] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[5] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Radiat Oncol & Radiol, Jinan, Shandong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11553
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Maintenance treatment with toripalimab and anlotinib after anthracycline-based chemotherapy in patients with advanced soft tissue sarcoma (TORAN): A single-arm, phase 2 trial
    Deng, Yaotiao
    Liu, Jie
    Li, Mei
    Jiang, Yu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Anlotinib plus Epirubicin Followed by Anlotinib Maintenance as First-line Treatment for Advanced Soft-tissue Sarcoma: An Open-label, Single-arm, Phase II Trial
    Wang, Zhi-ming
    Zhuang, Rong-yuan
    Guo, Xi
    Zhang, Chen-lu
    You, Yang
    Chen, Li-sha
    Liu, Wen-shuai
    Zhang, Yong
    Luo, Rong-kui
    Hou, Ying-yong
    Lu, Wei-qi
    Zhou, Yu-hong
    CLINICAL CANCER RESEARCH, 2022, 28 (24) : 5290 - 5296
  • [3] Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
    Wang, Hai-ying
    Chu, Jun-feng
    Zhang, Peng
    Wang, Jia-qiang
    Yan, Zheng
    Yao, Shu-na
    Yao, Zhi-hua
    Liu, Yan-yan
    ONCOTARGETS AND THERAPY, 2020, 13 : 1561 - 1568
  • [4] Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas
    Liu, Zhiyong
    Yao, Weitao
    Zhao, Yao
    Liu, Oufei
    Zhang, Peng
    Ge, Hong
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1009 - 1016
  • [5] The efficacy and safety of anlotinib combined with chemotherapy in treatment of advanced soft tissue sarcoma
    Ni, Ying
    Dong, Yabing
    Jiang, Aijun
    Zhang, Qun
    Wang, Zhantong
    Liang, Hui
    Zhang, Wei
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [6] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Yihebali Chi
    Guangqian Ji
    Jing Zhang
    Haijian Tang
    Yang Yang
    Wei Liu
    Nan Wang
    Chunhui Gao
    Yongkun Sun
    Jinwan Wang
    International Journal of Clinical Oncology, 2021, 26 : 1611 - 1618
  • [7] Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial
    Chi, Yihebali
    Ji, Guangqian
    Zhang, Jing
    Tang, Haijian
    Yang, Yang
    Liu, Wei
    Wang, Nan
    Gao, Chunhui
    Sun, Yongkun
    Wang, Jinwan
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1611 - 1618
  • [8] A single-arm, phase II clinical trial of neoadjuvant pegylated liposomal doxorubicin plus anlotinib in locally advanced soft tissue sarcoma
    Chen, Y.
    Sun, W.
    Wang, S.
    Xu, Y.
    Hu, T.
    Zheng, B.
    Sun, Z.
    Wang, C.
    Yan, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1045 - S1045
  • [9] First line anlotinib plus liposomal doxorubicin for locally advanced or metastatic soft tissue sarcoma: A prospective, single-arm trial
    Sun, Xin
    Zhang, Ranxin
    Xu, Jie
    Xie, Lu
    Guo, Wei
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2022, 15 (06) : 266 - 273
  • [10] First line anlotinib plus liposomal doxorubicin for locally advanced or metastatic soft tissue sarcoma: A prospective, single-arm trial
    Xin Sun
    Ranxin Zhang
    Jie Xu
    Lu Xie
    Wei Guo
    Asian Pacific Journal of Tropical Medicine, 2022, 15 (06) : 266 - 273
12345